Atlas Trials

An Observational Study for Evaluation of for the Prevalence of Cerebrotendinous Xanthomatosis (CTX) Disease

Clinical trial NCT04113083 · TERMINATED

Trial details

NCT number
NCT04113083
Sponsor
TRPHARM
Status
TERMINATED
Study type
OBSERVATIONAL
CTX - Cerebrotendinous Xanthomatosis
Start date
2019-10-19
Primary completion
2022-03-16
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.